BRSYF News and Press, Brainsway Ltd Ord From 03/25/21

BrainsWay Ltd. (BWAY) Q4 2020 Earnings Conference Call March 25, 2021 8:30 AM ET Company Participants Chase Oswald – LifeSci Advisors Christopher von Jako – President and Chief Executive Officer Hadar Levy – Senior Vice President and General Manager-North America and Inte...

FDA clearance for smoking cessation moves Brainsway towards a portfolio of neurological disorder treatments and extends the company’s competitive advantage. The publication of positive real-world results for treating OCD adds support to the case for insurance reimbursement, alt...

Brainsway Ltd. (BWAY) Q3 2020 Earnings Conference Call November 18, 2020 08:30 AM ET Company Participants Bob Yedid - LifeSci Advisors, Investor Relations Chris von Jako - President & Chief Executive Officer Judy Huber - Chief Financial Officer Conference Call Participants Steven Lichtman...

BrainsWay Ltd. (BWAY) Q2 2020 Earnings Conference Call August 12, 2020 08:30 ET Company Participants Bob Yedid - LifeSci Advisors, Investor Relations Christopher von Jako - President & Chief Executive Officer Judy Huber - Chief Financial Officer Conference Call Participant...

BrainsWay Ltd. (BWAY) Q1 2020 Earnings Conference Call June 24, 2020, 08:30 AM ET Company Participants Bob Yedid - MD, LifeSci Advisors, IR Christopher von Jako - President and CEO Judy Huber - Chief Financial Officer Conference Call Participants Jayson Bedford - Raymond J...

Brainsway Ltd. (BWAY) Q4 2019 Earnings Conference Call March 23, 2020 08:30 AM ET Company Participants Bob Yedid - LifeSci Advisors Christopher von Jako - CEO Hadar Levy - COO and CFO Conference Call Participants Craig Bijou - Cantor Fitzgerald Jayson Bedford - Raymond Ja...

Brainsway ( OTCPK:BRSYF ): Q4 Operating loss of $1.7M. More news on: Brainsway Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...

Neuronetics (STIM) recently released a solid quarterly report that included 30.94% revenue growth and a massive amount of cash. Almost 90% of its total amount of assets is represented by cash. The market did not seem to assess the figures reported and pushed the stock price down in November. A...

Brainsway ( OTCPK:BRSYF ) reports Q2  revenue growth of 54.2% Y/Y to $3.7M. More news on: Brainsway Ltd., Read more ...

Neuronetics, Inc. ( STIM ) is now trading at 8.32x forward sales after delivering a decent quarterly release with 28.5% revenue growth. The valuation seems too high if we compare with other peers, thus it may be time to liquidate the position. In this piece, there is further due diligence on...